ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Herbal Supplements and Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-15I17371
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Herbal Supplements and Medicine Market Research Report 2024
BUY CHAPTERS

Global Herbal Supplements and Medicine Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-15I17371
Report
October 2025
Pages:141
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica SE
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals

Herbal Supplements and Medicine Market

The global Herbal Supplements and Medicine market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Herbal supplements are products derived from plants, including their oils, roots, leaves, seeds, berries or flowers.
From a downstream perspective, Cardiovascular accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Herbal Supplements and Medicine leading manufacturers including Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, etc., dominate supply; the top five capture approximately % of global revenue, with Buchang Pharmaceuticals leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Herbal Supplements and Medicine market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Herbal Supplements and Medicine Market Report

Report Metric Details
Report Name Herbal Supplements and Medicine Market
Segment by Type
  • Prescription Drug
  • OTC
Segment by Application
  • Cardiovascular
  • Tumor
  • Respiratory System
  • Other
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Herbal Supplements and Medicine study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
  • Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 14: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Herbal Supplements and Medicine Market report?

Ans: The main players in the Herbal Supplements and Medicine Market are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals

What are the Application segmentation covered in the Herbal Supplements and Medicine Market report?

Ans: The Applications covered in the Herbal Supplements and Medicine Market report are Cardiovascular, Tumor, Respiratory System, Other

What are the Type segmentation covered in the Herbal Supplements and Medicine Market report?

Ans: The Types covered in the Herbal Supplements and Medicine Market report are Prescription Drug, OTC

1 Study Coverage
1.1 Introduction to Herbal Supplements and Medicine: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Herbal Supplements and Medicine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market Segmentation by Application
1.3.1 Global Herbal Supplements and Medicine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Herbal Supplements and Medicine Revenue Estimates and Forecasts 2020-2031
2.2 Global Herbal Supplements and Medicine Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Herbal Supplements and Medicine Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Herbal Supplements and Medicine Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Prescription Drug Market Size by Players
3.3.2 OTC Market Size by Players
3.4 Global Herbal Supplements and Medicine Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Herbal Supplements and Medicine Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Herbal Supplements and Medicine Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Herbal Supplements and Medicine Market Size by Type (2020-2031)
6.4 North America Herbal Supplements and Medicine Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Herbal Supplements and Medicine Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Herbal Supplements and Medicine Market Size by Type (2020-2031)
7.4 Europe Herbal Supplements and Medicine Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Herbal Supplements and Medicine Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Herbal Supplements and Medicine Market Size by Type (2020-2031)
8.4 Asia-Pacific Herbal Supplements and Medicine Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Herbal Supplements and Medicine Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Herbal Supplements and Medicine Market Size by Type (2020-2031)
9.4 Central and South America Herbal Supplements and Medicine Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Herbal Supplements and Medicine Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Herbal Supplements and Medicine Market Size by Type (2020-2031)
10.4 Middle East and Africa Herbal Supplements and Medicine Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Herbal Supplements and Medicine Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Corporation Information
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Herbal Supplements and Medicine Product Features and Attributes
11.1.4 Buchang Pharmaceuticals Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.1.5 Buchang Pharmaceuticals Herbal Supplements and Medicine Revenue by Product in 2024
11.1.6 Buchang Pharmaceuticals Herbal Supplements and Medicine Revenue by Application in 2024
11.1.7 Buchang Pharmaceuticals Herbal Supplements and Medicine Revenue by Geographic Area in 2024
11.1.8 Buchang Pharmaceuticals Herbal Supplements and Medicine SWOT Analysis
11.1.9 Buchang Pharmaceuticals Recent Developments
11.2 China TCM
11.2.1 China TCM Corporation Information
11.2.2 China TCM Business Overview
11.2.3 China TCM Herbal Supplements and Medicine Product Features and Attributes
11.2.4 China TCM Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.2.5 China TCM Herbal Supplements and Medicine Revenue by Product in 2024
11.2.6 China TCM Herbal Supplements and Medicine Revenue by Application in 2024
11.2.7 China TCM Herbal Supplements and Medicine Revenue by Geographic Area in 2024
11.2.8 China TCM Herbal Supplements and Medicine SWOT Analysis
11.2.9 China TCM Recent Developments
11.3 Tsumura
11.3.1 Tsumura Corporation Information
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Herbal Supplements and Medicine Product Features and Attributes
11.3.4 Tsumura Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.3.5 Tsumura Herbal Supplements and Medicine Revenue by Product in 2024
11.3.6 Tsumura Herbal Supplements and Medicine Revenue by Application in 2024
11.3.7 Tsumura Herbal Supplements and Medicine Revenue by Geographic Area in 2024
11.3.8 Tsumura Herbal Supplements and Medicine SWOT Analysis
11.3.9 Tsumura Recent Developments
11.4 Schwabe
11.4.1 Schwabe Corporation Information
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Herbal Supplements and Medicine Product Features and Attributes
11.4.4 Schwabe Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.4.5 Schwabe Herbal Supplements and Medicine Revenue by Product in 2024
11.4.6 Schwabe Herbal Supplements and Medicine Revenue by Application in 2024
11.4.7 Schwabe Herbal Supplements and Medicine Revenue by Geographic Area in 2024
11.4.8 Schwabe Herbal Supplements and Medicine SWOT Analysis
11.4.9 Schwabe Recent Developments
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Corporation Information
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Herbal Supplements and Medicine Product Features and Attributes
11.5.4 Tong Ren Tang Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.5.5 Tong Ren Tang Herbal Supplements and Medicine Revenue by Product in 2024
11.5.6 Tong Ren Tang Herbal Supplements and Medicine Revenue by Application in 2024
11.5.7 Tong Ren Tang Herbal Supplements and Medicine Revenue by Geographic Area in 2024
11.5.8 Tong Ren Tang Herbal Supplements and Medicine SWOT Analysis
11.5.9 Tong Ren Tang Recent Developments
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Corporation Information
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Herbal Supplements and Medicine Product Features and Attributes
11.6.4 Jumpcan Pharmaceutical Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.6.5 Jumpcan Pharmaceutical Recent Developments
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Corporation Information
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Herbal Supplements and Medicine Product Features and Attributes
11.7.4 Guangzhou Baiyunshan Pharmaceutical Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Corporation Information
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Herbal Supplements and Medicine Product Features and Attributes
11.8.4 Yunnan Baiyao Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.8.5 Yunnan Baiyao Recent Developments
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Corporation Information
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Herbal Supplements and Medicine Product Features and Attributes
11.9.4 Tasly Holding Group Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.9.5 Tasly Holding Group Recent Developments
11.10 Bionorica Se
11.10.1 Bionorica Se Corporation Information
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Herbal Supplements and Medicine Product Features and Attributes
11.10.4 Bionorica Se Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
11.11 Huarun 999
11.11.1 Huarun 999 Corporation Information
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Herbal Supplements and Medicine Product Features and Attributes
11.11.4 Huarun 999 Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.11.5 Huarun 999 Recent Developments
11.12 Taiji
11.12.1 Taiji Corporation Information
11.12.2 Taiji Business Overview
11.12.3 Taiji Herbal Supplements and Medicine Product Features and Attributes
11.12.4 Taiji Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.12.5 Taiji Recent Developments
11.13 Weleda
11.13.1 Weleda Corporation Information
11.13.2 Weleda Business Overview
11.13.3 Weleda Herbal Supplements and Medicine Product Features and Attributes
11.13.4 Weleda Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.13.5 Weleda Recent Developments
11.14 Kwangdong
11.14.1 Kwangdong Corporation Information
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Herbal Supplements and Medicine Product Features and Attributes
11.14.4 Kwangdong Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.14.5 Kwangdong Recent Developments
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Corporation Information
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Herbal Supplements and Medicine Product Features and Attributes
11.15.4 GW Pharmaceuticals Herbal Supplements and Medicine Revenue and Gross Margin (2020-2025)
11.15.5 GW Pharmaceuticals Recent Developments
12 Herbal Supplements and MedicineIndustry Chain Analysis
12.1 Herbal Supplements and Medicine Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Herbal Supplements and Medicine Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Herbal Supplements and Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Buchang Pharmaceuticals
China TCM
Tsumura
Schwabe
Tong Ren Tang
Jumpcan Pharmaceutical
Guangzhou Baiyunshan Pharmaceutical
Yunnan Baiyao
Tasly Holding Group
Bionorica SE
Huarun 999
Taiji
Weleda
Kwangdong
GW Pharmaceuticals
List of Tables
 Table 1. Global Herbal Supplements and Medicine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Herbal Supplements and Medicine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Herbal Supplements and Medicine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Herbal Supplements and Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Herbal Supplements and Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 7. Global Herbal Supplements and Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 8. Global Herbal Supplements and Medicine Revenue Market Share by Players (2020-2025)
 Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 10. Global Herbal Supplements and Medicine by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Herbal Supplements and Medicine as of 2024)
 Table 11. Global Herbal Supplements and Medicine Average Gross Margin (%) by Player (2020 VS 2024)
 Table 12. Global Herbal Supplements and Medicine Companies Headquarters
 Table 13. Global Herbal Supplements and Medicine Market Concentration Ratio (CR5 and HHI)
 Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 16. Global Herbal Supplements and Medicine Revenue by Type (2020-2025) & (US$ Million)
 Table 17. Global Herbal Supplements and Medicine Revenue by Type (2026-2031) & (US$ Million)
 Table 18. Key Product Attributes and Differentiation
 Table 19. Global Herbal Supplements and Medicine Revenue by Application (2020-2025) & (US$ Million)
 Table 20. Global Herbal Supplements and Medicine Revenue by Application (2026-2031) & (US$ Million)
 Table 21. Herbal Supplements and Medicine High-Growth Sectors Demand CAGR (2024-2031)
 Table 22. Top Customers by Region
 Table 23. Top Customers by Application
 Table 24. North America Herbal Supplements and Medicine Growth Accelerators and Market Barriers
 Table 25. North America Herbal Supplements and Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 26. Europe Herbal Supplements and Medicine Growth Accelerators and Market Barriers
 Table 27. Europe Herbal Supplements and Medicine Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. Asia-Pacific Herbal Supplements and Medicine Growth Accelerators and Market Barriers
 Table 29. Asia-Pacific Herbal Supplements and Medicine Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 30. Central and South America Herbal Supplements and Medicine Investment Opportunities and Key Challenges
 Table 31. Central and South America Herbal Supplements and Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 32. Middle East and Africa Herbal Supplements and Medicine Investment Opportunities and Key Challenges
 Table 33. Middle East and Africa Herbal Supplements and Medicine Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 34. Buchang Pharmaceuticals Corporation Information
 Table 35. Buchang Pharmaceuticals Description and Major Businesses
 Table 36. Buchang Pharmaceuticals Product Features and Attributes
 Table 37. Buchang Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 38. Buchang Pharmaceuticals Revenue Proportion by Product in 2024
 Table 39. Buchang Pharmaceuticals Revenue Proportion by Application in 2024
 Table 40. Buchang Pharmaceuticals Revenue Proportion by Geographic Area in 2024
 Table 41. Buchang Pharmaceuticals Herbal Supplements and Medicine SWOT Analysis
 Table 42. Buchang Pharmaceuticals Recent Developments
 Table 43. China TCM Corporation Information
 Table 44. China TCM Description and Major Businesses
 Table 45. China TCM Product Features and Attributes
 Table 46. China TCM Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. China TCM Revenue Proportion by Product in 2024
 Table 48. China TCM Revenue Proportion by Application in 2024
 Table 49. China TCM Revenue Proportion by Geographic Area in 2024
 Table 50. China TCM Herbal Supplements and Medicine SWOT Analysis
 Table 51. China TCM Recent Developments
 Table 52. Tsumura Corporation Information
 Table 53. Tsumura Description and Major Businesses
 Table 54. Tsumura Product Features and Attributes
 Table 55. Tsumura Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 56. Tsumura Revenue Proportion by Product in 2024
 Table 57. Tsumura Revenue Proportion by Application in 2024
 Table 58. Tsumura Revenue Proportion by Geographic Area in 2024
 Table 59. Tsumura Herbal Supplements and Medicine SWOT Analysis
 Table 60. Tsumura Recent Developments
 Table 61. Schwabe Corporation Information
 Table 62. Schwabe Description and Major Businesses
 Table 63. Schwabe Product Features and Attributes
 Table 64. Schwabe Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 65. Schwabe Revenue Proportion by Product in 2024
 Table 66. Schwabe Revenue Proportion by Application in 2024
 Table 67. Schwabe Revenue Proportion by Geographic Area in 2024
 Table 68. Schwabe Herbal Supplements and Medicine SWOT Analysis
 Table 69. Schwabe Recent Developments
 Table 70. Tong Ren Tang Corporation Information
 Table 71. Tong Ren Tang Description and Major Businesses
 Table 72. Tong Ren Tang Product Features and Attributes
 Table 73. Tong Ren Tang Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 74. Tong Ren Tang Revenue Proportion by Product in 2024
 Table 75. Tong Ren Tang Revenue Proportion by Application in 2024
 Table 76. Tong Ren Tang Revenue Proportion by Geographic Area in 2024
 Table 77. Tong Ren Tang Herbal Supplements and Medicine SWOT Analysis
 Table 78. Tong Ren Tang Recent Developments
 Table 79. Jumpcan Pharmaceutical Corporation Information
 Table 80. Jumpcan Pharmaceutical Description and Major Businesses
 Table 81. Jumpcan Pharmaceutical Product Features and Attributes
 Table 82. Jumpcan Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 83. Jumpcan Pharmaceutical Recent Developments
 Table 84. Guangzhou Baiyunshan Pharmaceutical Corporation Information
 Table 85. Guangzhou Baiyunshan Pharmaceutical Description and Major Businesses
 Table 86. Guangzhou Baiyunshan Pharmaceutical Product Features and Attributes
 Table 87. Guangzhou Baiyunshan Pharmaceutical Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 88. Guangzhou Baiyunshan Pharmaceutical Recent Developments
 Table 89. Yunnan Baiyao Corporation Information
 Table 90. Yunnan Baiyao Description and Major Businesses
 Table 91. Yunnan Baiyao Product Features and Attributes
 Table 92. Yunnan Baiyao Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 93. Yunnan Baiyao Recent Developments
 Table 94. Tasly Holding Group Corporation Information
 Table 95. Tasly Holding Group Description and Major Businesses
 Table 96. Tasly Holding Group Product Features and Attributes
 Table 97. Tasly Holding Group Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 98. Tasly Holding Group Recent Developments
 Table 99. Bionorica Se Corporation Information
 Table 100. Bionorica Se Description and Major Businesses
 Table 101. Bionorica Se Product Features and Attributes
 Table 102. Bionorica Se Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. Bionorica Se Recent Developments
 Table 104. Huarun 999 Corporation Information
 Table 105. Huarun 999 Description and Major Businesses
 Table 106. Huarun 999 Product Features and Attributes
 Table 107. Huarun 999 Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 108. Huarun 999 Recent Developments
 Table 109. Taiji Corporation Information
 Table 110. Taiji Description and Major Businesses
 Table 111. Taiji Product Features and Attributes
 Table 112. Taiji Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 113. Taiji Recent Developments
 Table 114. Weleda Corporation Information
 Table 115. Weleda Description and Major Businesses
 Table 116. Weleda Product Features and Attributes
 Table 117. Weleda Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 118. Weleda Recent Developments
 Table 119. Kwangdong Corporation Information
 Table 120. Kwangdong Description and Major Businesses
 Table 121. Kwangdong Product Features and Attributes
 Table 122. Kwangdong Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 123. Kwangdong Recent Developments
 Table 124. GW Pharmaceuticals Corporation Information
 Table 125. GW Pharmaceuticals Description and Major Businesses
 Table 126. GW Pharmaceuticals Product Features and Attributes
 Table 127. GW Pharmaceuticals Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 128. GW Pharmaceuticals Recent Developments
 Table 129. Raw Materials Key Suppliers
 Table 130. Distributors List
 Table 131. Market Trends and Market Evolution
 Table 132. Market Drivers and Opportunities
 Table 133. Market Challenges, Risks, and Restraints
 Table 134. Research Programs/Design for This Report
 Table 135. Key Data Information from Secondary Sources
 Table 136. Key Data Information from Primary Sources


List of Figures
 Figure 1. Herbal Supplements and Medicine Product Picture
 Figure 2. Global Herbal Supplements and Medicine Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Prescription Drug Product Picture
 Figure 4. OTC Product Picture
 Figure 5. Global Herbal Supplements and Medicine Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Cardiovascular
 Figure 7. Tumor
 Figure 8. Respiratory System
 Figure 9. Other
 Figure 10. Herbal Supplements and Medicine Report Years Considered
 Figure 11. Global Herbal Supplements and Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Herbal Supplements and Medicine Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Herbal Supplements and Medicine Revenue Market Share by Region (2020-2031)
 Figure 15. Global Herbal Supplements and Medicine Revenue Market Share Ranking (2024)
 Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 17. Prescription Drug Revenue Market Share by Player in 2024
 Figure 18. OTC Revenue Market Share by Player in 2024
 Figure 19. Global Herbal Supplements and Medicine Revenue Market Share by Type (2020-2031)
 Figure 20. Global Herbal Supplements and Medicine Revenue Market Share by Application (2020-2031)
 Figure 21. North America Herbal Supplements and Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 22. North America Top 5 Players Herbal Supplements and Medicine Revenue (US$ Million) in 2024
 Figure 23. North America Herbal Supplements and Medicine Revenue (US$ Million) by Type (2020 - 2031)
 Figure 24. North America Herbal Supplements and Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 25. US Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 26. Canada Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 27. Mexico Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 28. Europe Herbal Supplements and Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. Europe Top 5 Players Herbal Supplements and Medicine Revenue (US$ Million) in 2024
 Figure 30. Europe Herbal Supplements and Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 31. Europe Herbal Supplements and Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 32. Germany Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 33. France Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 34. U.K. Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 35. Italy Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 36. Russia Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Herbal Supplements and Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Top 8 Players Herbal Supplements and Medicine Revenue (US$ Million) in 2024
 Figure 39. Asia-Pacific Herbal Supplements and Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Asia-Pacific Herbal Supplements and Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 41. Indonesia Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 42. Japan Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 43. South Korea Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 44. Australia Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 45. India Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 46. Indonesia Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 47. Vietnam Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 48. Malaysia Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 49. Philippines Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 50. Singapore Herbal Supplements and Medicine Revenue (2020-2031) & (US$ Million)
 Figure 51. Central and South America Herbal Supplements and Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Central and South America Top 5 Players Herbal Supplements and Medicine Revenue (US$ Million) in 2024
 Figure 53. Central and South America Herbal Supplements and Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 54. Central and South America Herbal Supplements and Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Brazil Herbal Supplements and Medicine Revenue (2020-2025) & (US$ Million)
 Figure 56. Argentina Herbal Supplements and Medicine Revenue (2020-2025) & (US$ Million)
 Figure 57. Middle East and Africa Herbal Supplements and Medicine Revenue YoY (2020-2031) & (US$ Million)
 Figure 58. Middle East and Africa Top 5 Players Herbal Supplements and Medicine Revenue (US$ Million) in 2024
 Figure 59. South America Herbal Supplements and Medicine Revenue (US$ Million) by Type (2020-2031)
 Figure 60. Middle East and Africa Herbal Supplements and Medicine Revenue (US$ Million) by Application (2020-2031)
 Figure 61. GCC Countries Herbal Supplements and Medicine Revenue (2020-2025) & (US$ Million)
 Figure 62. Israel Herbal Supplements and Medicine Revenue (2020-2025) & (US$ Million)
 Figure 63. Egypt Herbal Supplements and Medicine Revenue (2020-2025) & (US$ Million)
 Figure 64. South Africa Herbal Supplements and Medicine Revenue (2020-2025) & (US$ Million)
 Figure 65. Herbal Supplements and Medicine Industry Chain Mapping
 Figure 66. Channels of Distribution (Direct Vs Distribution)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Botanical Supplement and Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Botanical Dietary Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Herbal Dietary Supplements Market Research Report 2024
Global Plant Based Supplement Market Research Report 2024
Global Vitamins And Herbal Dietary Supplements Market Research Report 2024
Global Herbal Extract Health Products Market Research Report 2025
Global Herbal Liver Health Products Market Research Report 2025
Global Herbal Beauty Supplement Market Insights Forecast to 2030
Global Herbal Medicinal Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Herbal Dietary Supplement Market Insights Forecast to 2030
Global Spice Supplements Market Research Report 2024
Global Plant based Immune Health Supplement Market Research Report 2024
Global Herbal Extracts Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Herbal Food Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Women Health and Beauty Supplement Market Research Report 2024
Global OTC Herbal and Traditional Medicines Market Insights Forecast to 2030
Global Herbal Medicine Market Insights Forecast to 2030
Global Essential Oil Supplement Market Research Report 2025
Global Botanical Medicine Market Research Report 2024
Global Herbal Flower Seeds Market Research Report 2024

RELATED REPORTS

Global Organic Zinc Supplements Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38U19850
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Egg Protein Hydrolysates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Z20517
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global PAC Flocculant Dosing Device Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28R19905
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Polyaspartic Acid Magnesium Salt(PASP-Mg) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17G20275
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions